Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

C Monaca1, P Franco2, P Philip3

  • 1Unité des troubles du sommeil, neurophysiologie clinique, CHRU de Lille, 2, avenue Oscar-Lambret, 59000 Lille, France; Inserm U1171, 59000 Lille, France.

Revue Neurologique
|November 14, 2016
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Digital health technology in oncology: results from a survey by the ESMO Young Oncologists Committee and medical student alumni.

ESMO real world data and digital oncology·2026
Same author

Pediatric obstructive sleep apnea hypopnea diagnosis using a video recording score: A pilot study.

European annals of otorhinolaryngology, head and neck diseases·2026
Same author

Validation of a prognostic nomogram for locally advanced oropharyngeal carcinoma treated with intensity-modulated radiotherapy with/without systemic therapy.

ESMO open·2025
Same author

The use of bone-modifying agents in early breast cancer: AIOM Guidelines update and perspectives.

Tumori·2025
Same author

A multicenter retrospective analysis of recurrent/metastatic nasopharyngeal cancer from non-endemic areas: Results in the pre-immunotherapy era.

European journal of cancer (Oxford, England : 1990)·2025
Same author

Hypocretinergic dysfunction in neuromyelitis optica with coma-like episodes.

BMJ case reports·2025
Same journal

Macrophage inclusions in patients undergoing antisense oligonucleotide therapy for ALS or SMA: A retrospective and transversal study.

Revue neurologique·2026
Same journal

Geographic disparities in MRI features of ischemic stroke and small vessel disease: A comparative study between French Guiana and mainland France. Findings from the BECATOUR multicenter registry.

Revue neurologique·2026
Same journal

Continuous subcutaneous perfusion of apomorphine in Parkinson's disease: Towards monotherapy?

Revue neurologique·2026
Same journal

Neuro-Whipple presenting as autoimmune encephalitis.

Revue neurologique·2026
Same journal

Multimodal assessment of minimally conscious state and cognitive motor dissociation in neurocritical care: A critical review.

Revue neurologique·2026
Same journal

Development of a new episodic memory assessment tool (NEM): Preliminary data and clinical perspectives.

Revue neurologique·2026
See all related articles

Narcolepsy is now classified into two types: NT1 with cataplexy and hypocretin neuron loss, and NT2 without. This consensus provides diagnostic and follow-up recommendations for narcolepsy patients.

Area of Science:

  • Neurology
  • Sleep Medicine
  • Immunology

Background:

  • The International Classification of Sleep Disorders-3 distinguishes narcolepsy into type 1 (NT1) and type 2 (NT2).
  • NT1 is associated with hypocretin neuron loss and often presents with cataplexy, while NT2 lacks cataplexy and has normal hypocretin levels.
  • Understanding these distinctions is crucial for accurate diagnosis and management.

Purpose of the Study:

  • To propose recommendations for the diagnostic work-up and follow-up of narcolepsy patients.
  • To clarify the diagnostic criteria differentiating NT1 and NT2.
  • To guide clinicians in selecting appropriate investigations based on clinical presentation.

Main Methods:

  • Review of current diagnostic criteria for narcolepsy (ICSD-3).
Keywords:
BiomarkerCataplexyHypocretin/orexineNarcolepsySomnolence

Related Experiment Videos

  • Analysis of differentiating features between NT1 and NT2, including cataplexy and hypocretin levels.
  • Proposal of a diagnostic and follow-up pathway based on clinical presentation and investigation results.

    • Main Results:

    • Narcolepsy classification differentiates NT1 (with cataplexy, hypocretin deficiency) and NT2 (without cataplexy, normal hypocretin).
    • Diagnostic confirmation involves polysomnography and multiple sleep latency tests.
    • Further investigations like HLA typing, CSF hypocretin measurement, or brain imaging are guided by the presence of cataplexy or suspicion of secondary narcolepsy.

    Conclusions:

    • Established recommendations for the diagnosis and follow-up of narcolepsy.
    • Emphasized the importance of differentiating NT1 and NT2 for appropriate patient management.
    • Highlighted the role of specific investigations in confirming the narcolepsy subtype and identifying potential secondary causes.